image
Healthcare - Biotechnology - NASDAQ - US
$ 1.535
4.11 %
$ 8.54 M
Market Cap
-0.06
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
20.96%
EBIT Estimate
85.89%
Net Income Estimate
--63.96%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Traws Pharma, Inc.
image
TRAW has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart TRAW

image
$12.0m$12.0m$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.02015201520162016201720172018201820192019202020202021202120222022202320232024202420252025202620262027202720282028
EBIT FORECAST

EBIT Forecast Chart TRAW

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)2015201520162016201720172018201820192019202020202021202120222022202320232024202420252025202620262027202720282028
NET INCOME FORECAST

Net Income Chart TRAW

image
$0.0$0.0($200.0b)($200.0b)($400.0b)($400.0b)($600.0b)($600.0b)($800.0b)($800.0b)($1.0t)($1.0t)($1.2t)($1.2t)($1.4t)($1.4t)($1.6t)($1.6t)($1.8t)($1.8t)2015201520162016201720172018201820192019202020202021202120222022202320232024202420252025202620262027202720282028